Imatinib Mesylate in the Treatment of Chronic Myeloid Leukaemia
Now:
AED 222.00 Inclusive of VAT
Free Delivery
Get it by 25 - 26 Feb
Earn 5% cashback with the Mashreq noon Credit Card. Apply now
1
Free delivery on Lockers & Pickup Points
Learn more
Enjoy hassle free returns with this offer.
Item as Described
70%
Partner Since
7+ YearsSpecifications
| Publisher | LAP Lambert Academic Publishing; Standard Edition |
| ISBN 13 | 9783838355832 |
| ISBN 10 | 3838355830 |
| Author | Ping Chong Bee |
| Language | English |
| Book Description | Imatinib mesylate is a novel drug which targets the molecular level in chronic myeloid leukaemia. The response rates in various studies were very impressive. There is no study of efficacy and adverse effects of imatinib mesylate in our local patients. It is generally believed that these would be similar to that of Western patients. However, physical and genetic differences may influence the effects of imatinib mesylate in Asian patients. |
| Publication Date | 6 July 2010 |
| Number of Pages | 68 pages |
Imatinib Mesylate in the Treatment of Chronic Myeloid Leukaemia
Added to cart
Cart Total AED 222.00
